Every Challenge Has a Backstory
The footprints of many pharmaceutical companies have changed over the past two decades. Mergers among top global players and more efficient workspaces have changed the focus of many companies toward consolidation, divestiture, and creating flexible spaces for biopharmaceutical manufacturing processes. These companies have undertaken consolidation programs to reduce their footprint, maximize building efficiency, improve workplace environments, and reduce operating costs.
In line with these industry challenges, a major pharmaceutical and healthcare company sought a strategic partner to help implement environmental remediation, abatement, decontamination, demolition, and redevelopment programs at research and manufacturing facilities across the U.S.